219 related articles for article (PubMed ID: 21224724)
1. Transgenic overexpression of PKCε in the mouse prostate induces preneoplastic lesions.
Benavides F; Blando J; Perez CJ; Garg R; Conti CJ; DiGiovanni J; Kazanietz MG
Cell Cycle; 2011 Jan; 10(2):268-77. PubMed ID: 21224724
[TBL] [Abstract][Full Text] [Related]
2. A tale of three PKCs: epsilon emerges as a driver of pre-neoplastic phenotypes.
Knudsen KE
Cell Cycle; 2011 Feb; 10(3):379. PubMed ID: 21270526
[No Abstract] [Full Text] [Related]
3. Cooperation between Stat3 and Akt signaling leads to prostate tumor development in transgenic mice.
Blando JM; Carbajal S; Abel E; Beltran L; Conti C; Fischer S; DiGiovanni J
Neoplasia; 2011 Mar; 13(3):254-65. PubMed ID: 21390188
[TBL] [Abstract][Full Text] [Related]
4. The pace of prostatic intraepithelial neoplasia development is determined by the timing of Pten tumor suppressor gene excision.
Luchman HA; Benediktsson H; Villemaire ML; Peterson AC; Jirik FR
PLoS One; 2008; 3(12):e3940. PubMed ID: 19081794
[TBL] [Abstract][Full Text] [Related]
5. Protein kinase Cepsilon interacts with signal transducers and activators of transcription 3 (Stat3), phosphorylates Stat3Ser727, and regulates its constitutive activation in prostate cancer.
Aziz MH; Manoharan HT; Church DR; Dreckschmidt NE; Zhong W; Oberley TD; Wilding G; Verma AK
Cancer Res; 2007 Sep; 67(18):8828-38. PubMed ID: 17875724
[TBL] [Abstract][Full Text] [Related]
6. Activation of nuclear factor κB (NF-κB) in prostate cancer is mediated by protein kinase C epsilon (PKCepsilon).
Garg R; Blando J; Perez CJ; Wang H; Benavides FJ; Kazanietz MG
J Biol Chem; 2012 Oct; 287(44):37570-82. PubMed ID: 22955280
[TBL] [Abstract][Full Text] [Related]
7. PKCε paves the way for prostate cancer.
Basu A
Cell Cycle; 2011 Feb; 10(3):378. PubMed ID: 21270525
[No Abstract] [Full Text] [Related]
8. Genetic ablation of PKC epsilon inhibits prostate cancer development and metastasis in transgenic mouse model of prostate adenocarcinoma.
Hafeez BB; Zhong W; Weichert J; Dreckschmidt NE; Jamal MS; Verma AK
Cancer Res; 2011 Mar; 71(6):2318-27. PubMed ID: 21406403
[TBL] [Abstract][Full Text] [Related]
9. Chronic activity of ectopic type 1 fibroblast growth factor receptor tyrosine kinase in prostate epithelium results in hyperplasia accompanied by intraepithelial neoplasia.
Wang F; McKeehan K; Yu C; Ittmann M; McKeehan WL
Prostate; 2004 Jan; 58(1):1-12. PubMed ID: 14673947
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of PKCepsilon sensitizes LNCaP human prostate cancer cells to induction of apoptosis by bryostatin 1.
Powell CT; Yin L
Int J Cancer; 2006 Mar; 118(6):1572-6. PubMed ID: 16184549
[TBL] [Abstract][Full Text] [Related]
11. Tissue-specific conditional PKCε knockout mice: a model to precisely reveal PKCε functional role in initiation, promotion and progression of cancer.
Hafeez BB; Meske L; Singh A; Singh A; Zhong W; Powers P; John M; Griep AE; Verma AK
Oncotarget; 2016 May; 7(22):33069-80. PubMed ID: 27102301
[TBL] [Abstract][Full Text] [Related]
12. Regulation of prostate cancer cell survival by protein kinase Cepsilon involves bad phosphorylation and modulation of the TNFalpha/JNK pathway.
Meshki J; Caino MC; von Burstin VA; Griner E; Kazanietz MG
J Biol Chem; 2010 Aug; 285(34):26033-40. PubMed ID: 20566643
[TBL] [Abstract][Full Text] [Related]
13. Long chain n-3 polyunsaturated fatty acids increase the efficacy of docetaxel in mammary cancer cells by downregulating Akt and PKCε/δ-induced ERK pathways.
Chauvin L; Goupille C; Blanc C; Pinault M; Domingo I; Guimaraes C; Bougnoux P; Chevalier S; Mahéo K
Biochim Biophys Acta; 2016 Apr; 1861(4):380-90. PubMed ID: 26821209
[TBL] [Abstract][Full Text] [Related]
14. MYC cooperates with AKT in prostate tumorigenesis and alters sensitivity to mTOR inhibitors.
Clegg NJ; Couto SS; Wongvipat J; Hieronymus H; Carver BS; Taylor BS; Ellwood-Yen K; Gerald WL; Sander C; Sawyers CL
PLoS One; 2011 Mar; 6(3):e17449. PubMed ID: 21394210
[TBL] [Abstract][Full Text] [Related]
15. PKCε inhibits isolation and stemness of side population cells via the suppression of ABCB1 transporter and PI3K/Akt, MAPK/ERK signaling in renal cell carcinoma cell line 769P.
Huang B; Fu SJ; Fan WZ; Wang ZH; Chen ZB; Guo SJ; Chen JX; Qiu SP
Cancer Lett; 2016 Jun; 376(1):148-54. PubMed ID: 27037060
[TBL] [Abstract][Full Text] [Related]
16. Protein kinase C negatively regulates Akt activity and modifies UVC-induced apoptosis in mouse keratinocytes.
Li L; Sampat K; Hu N; Zakari J; Yuspa SH
J Biol Chem; 2006 Feb; 281(6):3237-43. PubMed ID: 16338928
[TBL] [Abstract][Full Text] [Related]
17. Androgen-dependent prostate epithelial cell selection by targeting ARR(2)PBneo to the LPB-Tag model of prostate cancer.
Wang Y; Kasper S; Yuan J; Jin RJ; Zhang J; Ishii K; Wills ML; Hayward SW; Matusik RJ
Lab Invest; 2006 Oct; 86(10):1074-88. PubMed ID: 16894353
[TBL] [Abstract][Full Text] [Related]
18. Plumbagin Inhibits Prostate Carcinogenesis in Intact and Castrated PTEN Knockout Mice via Targeting PKCε, Stat3, and Epithelial-to-Mesenchymal Transition Markers.
Hafeez BB; Fischer JW; Singh A; Zhong W; Mustafa A; Meske L; Sheikhani MO; Verma AK
Cancer Prev Res (Phila); 2015 May; 8(5):375-86. PubMed ID: 25627799
[TBL] [Abstract][Full Text] [Related]
19. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
[TBL] [Abstract][Full Text] [Related]
20. Protein kinase Cepsilon (PKCepsilon) and Src control PKCdelta activation loop phosphorylation in cardiomyocytes.
Rybin VO; Guo J; Gertsberg Z; Elouardighi H; Steinberg SF
J Biol Chem; 2007 Aug; 282(32):23631-8. PubMed ID: 17569658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
